ask="9.76"
ask_size="100"
average_daily_volume="58058"
bid="4.67"
bid_size="1000"
book_value="0.00"
change="-0.02"
change_from_200_day_moving_average="0.74"
change_from_50_day_moving_average="0.05"
change_from_52_week_high="-3.90"
change_From_52_week_low="2.35"
change_in_percent="-0.40%"
close="5.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.38"
ebitda="0.00"
eps_estimate_current_year="-0.63"
eps_estimate_next_quarter="-0.70"
eps_estimate_next_year="-2.28"
ex_dividend_date="N/A"
float_shares="N/A"
high="5.14"
high_52_weeks="8.90"
last_trade_date="3/15/2017"
last_trade_price="5.00"
last_trade_size="280"
last_trade_time="4:00pm"
low="4.99"
low_52_weeks="2.65"
market_capitalization="N/A"
moving_average_200_day="4.26"
moving_average_50_day="4.95"
name="Caladrius Biosciences
Inc."
notes="N/A"
one_year_target_price="6.75"
open="4.99"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+17.35%"
percent_change_from_50_day_moving_average="+0.96%"
percent_change_from_52_week_high="-43.82%"
percent_change_from_52_week_low="+88.68%"
previous_close="5.02"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NCM"
symbol="CLBS"
volume="12656"
weeks_range_52="2.65 - 8.90"
